StartupsTechCrunchabout 10 hours ago
Colossal Biosciences seeks $20B-$30B valuation
1 min read
De-extinction startup Colossal Biosciences is in talks to raise new capital at a $20 billion to $30 billion valuation, up from its previous $10.2 billion valuation. The five-year-old company has started generating revenue and has spun out three startups including Breaking, Form Bio, and Astromech.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
